Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.100 | 0.879 | 33 | 2001 | 2020 | ||||
Hypertensive disease
|
1085 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.100 | 1.000 | 14 | 2003 | 2015 | ||||
Obesity
|
1111 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.080 | 0.875 | 8 | 2003 | 2018 | ||||
Diabetes Mellitus
|
824 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.060 | 0.833 | 6 | 2004 | 2018 | ||||
Diabetes
|
710 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.050 | 0.800 | 5 | 2004 | 2018 | ||||
Metabolic Syndrome X
|
591 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.040 | 0.750 | 4 | 2005 | 2020 | ||||
Coronary Artery Disease
|
1577 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.030 | 1.000 | 3 | 2008 | 2016 | ||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||
Polycystic Ovary Syndrome
|
363 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Essential Hypertension
|
293 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.020 | 0.500 | 2 | 2004 | 2014 | ||||
Gestational Diabetes
|
224 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.020 | 0.500 | 2 | 2007 | 2017 | ||||
Impaired glucose tolerance
|
81 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.020 | 1.000 | 2 | 2004 | 2005 | ||||
Metabolic Diseases
|
50 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.020 | 1.000 | 2 | 2006 | 2018 | ||||
Parkinson Disease
|
990 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.020 | 0.500 | 2 | 2011 | 2018 | ||||
Angina, Unstable
|
21 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Coronary Arteriosclerosis
|
440 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Diabetic Nephropathy
|
238 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Diabetic Retinopathy
|
213 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1 | 2005 | 2005 | |||||
Fatty Liver Disease
|
81 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Hyperinsulinism
|
64 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Hypertrophic Cardiomyopathy
|
635 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Kidney Diseases
|
140 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Left ventricular diastolic dysfunction
|
1 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Left Ventricular Hypertrophy
|
67 | 0.667 | 0.440 | 4 | 23814039 | missense variant | C/T | snv | 0.31 | 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 |